NCT05798923: An ongoing trial by OrphAI Therapeutics
This trial is ongoing. It must report results 5 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05798923 |
|---|---|
| Title | A Phase 2a Single-Arm, Open-Label, Exploratory Study to Assess the Effects of LAM-001 for the Treatment of Pulmonary Hypertension |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 3, 2023 |
| Completion date | May 16, 2025 |
| Required reporting date | May 16, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |